Zomer, H. D., Jeremias, T. da S., Ratner, B., & Trentin, A. G. (2020). Mesenchymal stromal cells from dermal and adipose tissues induce macrophage polarization to a pro-repair phenotype and improve skin wound healing. Cytotherapy, 22(5), 247–260. https://doi.org/10.1016/j.jcyt.2020.02.003

Liau, L.L., Looi, Q.H., Chia, W.C. et al. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci 10, 112 (2020). https://doi.org/10.1186/s13578-020-00475-3

Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021). Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Proliferation, 54(1). https://doi.org/10.1111/cpr.12956

Kunze, K.N., Burnett, R.A., Wright-Chisem, J. et al. Adipose-Derived Mesenchymal Stem Cell Treatments and Available Formulations. Curr Rev Musculoskelet Med 13, 264–280 (2020). https://doi.org/10.1007/s12178-020-09624-0

Mikłosz, A., Nikitiuk, B. E., & Chabowski, A. (2022). Using adipose‐derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand? Obesity Reviews: An Official Journal of the International Association for the Study of Obesity, 23(5). https://doi.org/10.1111/obr.13413

Jiang, Y., Zhang, P., Zhang, X., Lv, L., & Zhou, Y. (2021). Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis. Cell Proliferation, 54(1). https://doi.org/10.1111/cpr.12956

Smojver, I., Katalinić, I., Bjelica, R., Gabrić, D., Matišić, V., Molnar, V., & Primorac, D. (2022). Mesenchymal stem cells based treatment in dental medicine: A narrative review. International Journal of Molecular Sciences, 23(3), 1662. https://doi.org/10.3390/ijms23031662

Zayed M, Iohara K. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019. Cell Transplantation. 2020;29. doi:10.1177/0963689720952089

Ueda, T., Inden, M., Ito, T., Kurita, H., & Hozumi, I. (2020). Characteristics and therapeutic potential of dental pulp stem cells on neurodegenerative diseases. Frontiers in neuroscience, 14. https://doi.org/10.3389/fnins.2020.00407 
Sharma, Y., Shobha, K., Sundeep, M., Pinnelli, V. B., Parveen, S., & Dhanushkodi, A. (2022). Neural basis of Dental Pulp Stem Cells and its potential application in Parkinson’s disease. CNS & Neurological Disorders Drug Targets, 21(1), 62–76. https://doi.org/10.2174/1871527320666210311122921 

Li, F., Wang, X., Shi, J., Wu, S., Xing, W., & He, Y. (2023). Anti-inflammatory effect of dental pulp stem cells. Frontiers in immunology, 14. https://doi.org/10.3389/fimmu.2023.1284868

Gorodetsky, R., & Aicher, W. K. (2021). Allogenic use of human placenta-derived stromal cells as a highly active subtype of mesenchymal stromal cells for cell-based therapies. International Journal of Molecular Sciences, 22(10), 5302. https://doi.org/10.3390/ijms22105302

Saleh, M., Taher, M., Sohrabpour, A.A. et al. Perspective of placenta derived mesenchymal stem cells in acute liver failure. Cell Biosci 10, 71 (2020). https://doi.org/10.1186/s13578-020-00433-z

Mathew, S.A., Naik, C., Cahill, P.A. et al. Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis. Cell. Mol. Life Sci. 77, 253–265 (2020). https://doi.org/10.1007/s00018-019-03268-1

Shirbaghaee, Z., Heidari Keshel, S., Rasouli, M. et al. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI). Stem Cell Res Ther 14, 174 (2023). https://doi.org/10.1186/s13287-023-03390-9

Muthu, S., Jeyaraman, M., Gulati, A., & Arora, A. (2021). Current evidence on mesenchymal stem cell therapy for traumatic spinal cord injury: systematic review and meta-analysis. Cytotherapy, 23(3), 186–197. https://doi.org/10.1016/j.jcyt.2020.09.007 
Liau, L.L., Looi, Q.H., Chia, W.C. et al. Treatment of spinal cord injury with mesenchymal stem cells. Cell Biosci 10, 112 (2020). https://doi.org/10.1186/s13578-020-00475-3 

Lv, X., Wang, L., Zou, X., & Huang, S. (2021). Umbilical cord mesenchymal stem cell therapy for regenerative treatment of rheumatoid arthritis: Opportunities and challenges. Drug Design, Development and Therapy, 15, 3927–3936. https://doi.org/10.2147/dddt.s323107

Chen, Y., Shen, H., Ding, Y., Yu, Y., Shao, L., & Shen, Z. (2021). The application of umbilical cord‐derived MSCs in cardiovascular diseases. Journal of Cellular and Molecular Medicine, 25(17), 8103–8114. https://doi.org/10.1111/jcmm.16830 

Barczewska, M., Maksymowicz, S., Zdolińska-Malinowska, I. et al. Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study. Stem Cell Rev and Rep 16, 922–932 (2020). https://doi.org/10.1007/s12015-020-10016-7 

Chu, M., Wang, H., Bian, L. et al. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia. Stem Cell Rev and Rep 18, 2152–2163 (2022). https://doi.org/10.1007/s12015-022-10398-w

Kamal, M. M., & Kassem, D. H. (2020). Therapeutic potential of Wharton’s jelly mesenchymal stem cells for diabetes: Achievements and challenges. Frontiers in cell and developmental biology, 8. https://doi.org/10.3389/fcell.2020.00016 

Saleh, M., Fotook Kiaei, S.Z. & Kavianpour, M. Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis. Stem Cell Res Ther 13, 71 (2022). https://doi.org/10.1186/s13287-022-02746-x 

Czarnecka A, Odziomek A, Murzyn M, Dubis J, Bagłaj-Oleszczuk M, Hyncewicz-Gwóźdź A. Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata. Adv Clin Exp Med. 2021;30(2):211–218. doi:10.17219/acem/132069 

Albu, S., Kumru, H., Coll, R., Vives, J., Vallés, M., Benito-Penalva, J., Rodríguez, L., Codinach, M., Hernández, J., Navarro, X., & Vidal, J. (2021). Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study. Cytotherapy, 23(2), 146–156. https://doi.org/10.1016/j.jcyt.2020.08.008 

Abe, Y., Ochiai, D., Sato, Y., Otani, T., Fukutake, M., Ikenoue, S., Kasuga, Y., & Tanaka, M. (2021). Amniotic fluid stem cells as a novel strategy for the treatment of fetal and neonatal neurological diseases. Placenta, 104, 247–252. https://doi.org/10.1016/j.placenta.2021.01.009 

Luo H, Wang Z, Qi F, Wang D. Applications of human amniotic fluid stem cells in wound healing. Chin Med J 2022;135:2272–2281. doi: 10.1097/CM9.0000000000002076 

Li, J., Zhou, Z., Wen, J., Jiang, F., & Xia, Y. (2020). Human amniotic mesenchymal stem cells promote endogenous bone regeneration. Frontiers in endocrinology, 11. https://doi.org/10.3389/fendo.2020.543623